Tom Lee, Fundstrat Global Advisors managing partner and head of research, appeared on CNBC to talk about his 2025 playbook.

AbbVie Inc (NYSE:ABBV)., a leading biopharmaceutical company with a market capitalization of $311.86 billion, has been at the forefront of the industry with its diverse portfolio of pharmaceuticals ...

AbbVie (ABBV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Tim Anderson from Bank of ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

James analyst Gary Nachman maintained an Outperform rating on AbbVie stock (NYSE:ABBV) with a $218.00 price target. The ...

Funding Freeze Sets Off New Fight Over Trump’s Vision for His Government President Trump’s order freezing trillions of dollars in federal grants and loans seeks to eliminate all spending on ...

Steep new fines — more than many people make in a month — have made the streets of Ho Chi Minh City and Hanoi less freewheeling than they used to be. By Damien Cave When Colombia’s ...

Heavy snow blanketed South Korea for the second consecutive day Tuesday, disrupting transportation services and causing traffic congestion for people heading to their hometowns for... Traffic on major ...

Get dialed in every Tuesday & Friday with quick updates on the world of crypto ...

Virgin Voyages has kicked off 2025 with a bang, with a 60 percent increase in revenue and a 40 percent jump in new bookings. MSC Cruises is bringing its fourth World-class ship to a world class ...